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ABSTRACT. This study aimed to estimate the radiation dose and cancer risk to adults in
England, the USA and Hong Kong associated with retrospectively and prospectively
electrocardiogram (ECG)-gated coronary computed tomography angiography (CTA)
using currently practised protocols in Hong Kong. The doses were simulated using the
ImPACT spreadsheet. For retrospectively ECG-gated CTAwith pitches of 0.2, 0.22 and 0.24,
the effective doseswere 27.7, 23.6 and 20.7 mSv, respectively, formales and 23.6, 20.0 and
18.8 mSv, respectively, for females. For prospectively ECG-gated CTA, the effective dose
was 3.7 mSv for both males and females. A table of lifetime attributable risks (LAR) of
cancer incidence was set up for the English population for the purpose of estimating
cancer risk induced by low-dose radiation exposure, as previously reported for US and
Hong Kong populations. From the tables, the LAR of cancer incidence for a representative
50-year-old subject was calculated for retrospectively ECG-gated CTA to be 0.112% and
0.227% for English males and females, respectively, 0.103% and 0.228% for US males and
females, respectively, and was comparatively higher at 0.137% and 0.370% for Hong
Kong males and females, respectively; for prospectively ECG-gated CTA, the
corresponding values were calculated to be 0.014% and 0.035% for English males and
females, respectively, and 0.013% and 0.036% for USmales and females, respectively, and
again were higher at 0.017% and 0.060% for Hong Kongmales and females, respectively.
Our study shows that prospectively ECG-gated CTA reduces radiation dose and cancer risks
by up to 87% compared with retrospectively ECG-gated CTA.
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Conventional coronary angiography is the gold standard
for assessing the heart and coronary arteries, owing to its
excellent spatial and temporal resolution; however, the
procedure is invasive and can cause serious complications,
such as thromboembolism and arterial dissection. Non-
invasive imaging methods such as computed tomography
angiography (CTA) can therefore be advantageous [1–4].
Applications of coronary artery CTA have, in the past, been
limited by problems such as cardiac motion, respiratory
motion and the small size of coronary arteries. However,
technological advances with multidetector CT (MDCT)
scanners have enhanced the spatial and temporal resolution
achievable by CTA. Moreover, applying electrocardiogram
(ECG)-gated technology, the data at diastole during each
cardiac cycle can be selected and used for image recon-
struction, thereby minimising motion artefacts [5]. There are
two kinds of ECG-gating technologies: retrospective ECG
gating and prospective ECG gating [5, 6]. For retrospective
ECG gating, data are acquired during the entire cardiac
cycle and only some of the data (data at the diastolic phase)
are used for image reconstruction. To obtain sufficient raw
data, data oversampling is used with a low pitch, which, in
turn, depends on the patient’s heart rate. For prospective
ECG gating, initially the mean duration of a cardiac cycle is
averaged over multiple heart cycles. The trigger, a
predefined time-point in each subsequent cardiac cycle, is
used to initiate a sequential axial scan during diastole. The
acquisition time for one axial position is about 250–500 ms.
All data acquired in prospectively ECG-gated scans are
used for image reconstruction.
With the advent of MDCT for coronary CTA, however,
radiation dose has become an important issue to be
considered [7, 8]. The doses reported from coronary CTA
may be even higher than for conventional angiography [9].
Using retrospectively ECG-gated CTA, doses to the organs
exposed directly to X-rays are especially high: up to 114 mSv
for oesophagus, 80 mSv for breast and 91 mSv for lung [10].
Recently, cancer risks from CTA, the major detriment
associated with radiation exposure, have been reported in
the literature [10–12]. These studies estimated lifetime cancer
incidence to be up to 0.2% and 0.7% for patients undergoing
coronary CTA on 16- and 64-slice CT scanners, respectively
[10, 12]. Moreover, a lifetime incidence of up to 0.5% and
0.4% was reported specifically for breast and lung cancer,
respectively [11]. Doses from prospectively ECG-gated CTA
have been reported and were found to be much lower than
those for retrospectively ECG-gated CTA [13, 14].
This study investigated the radiation dose from retro-
spectively and prospectively ECG-gated coronary CTA
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on 64-slice MDCT and compared the associated cancer
risk imparted to adults in England, the USA and Hong
Kong. Comparisons were based on the principles
introduced by the Biological Effects of Ionizing
Radiation (BEIR) Committee of the National Research
Council in its seventh report (BEIR VII report) [15].
Methods and materials
CT dose estimation
The radiation doses associated with coronary CTA on
64-slice LightSpeed VCT and LightSpeed VCT XT (GE
Healthcare, Milwaukee, WI) were evaluated. The com-
monly used CTA protocols for adults currently practised
in our clinic were studied. The scanning protocol of
retrospectively ECG-gated CTA performed using VCT
was as follows: 120 kV; 0.35 s rotation time; cardiac large
filter; slice acquisition 64 6 0.625 mm; 140 mA,700 mA
ECG-modulated tube current (full current between 40%
and ,80% of cardiac cycle, 140 mA for the rest of the
cycle); and a pitch of 0.2, 0.22 or 0.24, corresponding to
heart rates of 50 bpm, 60 bpm and 70 bpm, respectively.
Owing to overscans in helical scan mode for the
retrospectively ECG-gated CTA, we assumed a z-axis
scan range of 16 cm to cover the cardiac region of about
12 cm. The scanning protocol of prospectively ECG-
gated CTA using VCT XT was as follows: 120 kV;
450 mA; 0.35 s rotation time (half-scan, about
0.24 s ¡ 0.06 s padding); cardiac large filter; slice acqui-
sition 64 6 0.625 mm; and a z-axis range of 12 cm. These
protocols are similar to those reported in publications
from some centres in Europe, America and Asia [16–18],
although minor variations do exist.
To estimate the radiation dose of CTA, the spreadsheet
ImPACT Version 0.99X [19] was used. This is a widely
recognised tool for calculating patient organ doses and
effective doses from CT examinations [20–25] including
coronary angiography [21]. The scanner type, the CT
dose index (CTDI) of these two scanners and the protocol
parameters were input into the spreadsheet. The
spreadsheet makes use of the Monte Carlo dose data
published in the National Radiological Protection Board
(NRPB) Report SR250 [26] and the input data to
determine the organ doses from the CT scan. The
effective doses were calculated by summing these organ
doses weighted by organ weighting factors recom-
mended in International Commission on Radiological
Protection (ICRP) publication 103 [27].
Cancer risk estimation
Cancer risk estimation was performed by applying the
principles introduced in the BEIR VII report [15] in the
form of lifetime attributable risk (LAR), which is




M D,e,að ÞS að Þ=S eð Þ ð1Þ
where D is dose (assumed to be 100 mSv, for calculating
the table), e is exposed age and a is attained age which is
from e+L to 100 (L is a risk-free latent period that equals
5) accounting for ‘‘lifetime’’. S(a) and S(e) are the
probability of surviving until age a and e, respectively,
which are obtained in the life table data. Hence, the ratio
from S(a)/S(e) is the probability of patient surviving to
age a on the condition that he/she survives to age
e. M(D,e,a) is the excessive cancer risk in a specific year,
which can be calculated using the excess relative risk
(ERR) model and the excess absolute risk (EAR) model.
EAR is the excess absolute cancer risk, whereas, ERR is
the excess absolute cancer risk divided by the baseline
rate [15]. Using the ERR model, the ERRs are assumed to
be the same among different populations and M(D,e,a) is
given by Equation 2.
M D,e,að Þ~ERR D,e,að ÞlcI að Þ ð2Þ
where lcI að Þ represents sex- and age-specific baseline
cancer incidences (cases in 100 000 people), which can be
obtained from the cancer statistics. For the EAR model,
EARs are assumed to be constant among different
populations and equal to M(D,e,a). In the BEIR VII
report, ERR(D,e,a) and EAR(D,e,a) modelling are based
on the cohorts exposed to excess radiation, including A-
bomb survivors. Two LARs were acquired using the ERR
and EAR models, and a weighted LAR was then
calculated by weighting these two on a logarithmic scale.
In the BEIR VII report, to calculate the table for the US
population, weights of 0.3 for the EAR model and 0.7 for
the ERR model are given to most cancer sites, based on
an analysis of risk transport between the Japanese and
US population [15]. The final LAR table data were
acquired by dividing the weighted LAR D,eð Þ by a dose
and dose-rate effectiveness factor (DDREF) of 1.5, to
account for the lower risk of the low-dose radiation. In
this way, the LAR of each organ for 100 000 US subjects
exposed to 100 mSv radiation at a specific age was
derived and tabulated in the BEIR VII report. Each
organ’s LAR for a specific radiation dose can be
calculated according to data in the table and applying
linear extrapolation.
In our study, to calculate the LAR for the English
population, an LAR table similar to the one derived for
the US population in the BEIR VII report [15] was
calculated using the Cancer Registration Statistics
England 2005 [28] and United Kingdom Interim Life
Tables 2005–07 [29]. The weights of EAR and ERR for the
English population were chosen to be the same as those
used in the BEIR VII report for the US population, as no
weights were suggested for other populations in the
BEIR VII report. A DDREF of 1.5 was also used to
account for the lower risk of the low-dose radiation.
The tables of LAR for the USA and Hong Kong
population have been established and presented in our
previous publication [30]. We performed the analyses of
cancer risks for England, USA and Hong Kong adult
populations ranging between 20 and 80 years of age. To
study the detriment of the associated cancer risk, the
proportion of the total lifetime cancer incidence con-
tributed by the LAR was also calculated. The total
lifetime cancer incidence was calculated by summing the
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baseline lifetime cancer incidence acquired from the
cancer statistics [28, 31, 32] and the LAR.
Results
Radiation dose
Organ doses and effective doses from CTA performed
on LightSpeed VCT and LightSpeed VCT XT are
presented in Table 1. For females, the effective doses of
retrospectively ECG-gated coronary angiography with a
heart rate of 50 bpm, 60 bpm and 70 bpm (correspond-
ing to pitches of 0.2, 0.22 and 0.24, respectively) were
23.6 mSv, 20.0 mSv and 18.8 mSv, respectively; for
males, the corresponding values were 27.7 mSv,
23.6 mSv and 20.7 mSv, respectively. The effective doses
for males were higher than those for females. The organ
doses and effective doses decreased when the pitch
increased. A high radiation burden was observed in the
lung, breast and oesophagus, all of which were directly
exposed to radiation. Doses imparted to these directly
exposed organs ranged from 45 mSv to 73 mSv. The
organs not exposed directly, including gonad, colon and
bladder, contributed less than 6% of the overall effective
dose. The effective dose from prospectively ECG-gated
CTA was 3.7 mSv for both males and females, less than
one-quarter of the dose from retrospectively ECG-gated
coronary CTA. We also made a comparison table of
doses from other types of CT scans that have been
reported in the literature (Table 2).
Cancer risk
The LAR data calculated for the English population
are presented in Table 3. The table shows lifetime cancer
cases per 100 000 persons (males or females, indepen-
dently) exposed to 100 mSv radiation. As shown in the
table, the excess risks for females are higher than for
males, except for colon and liver.
LARs of cancer incidence induced by the radiation
dose for English (Figure 1a,b), USA (Figure 1c,d) and
Hong Kong (Figure 1e and f) populations from 20 to 80
years of age are illustrated in Figure 1. We used 50-year-
old subjects as representative examples. For retrospec-
tively ECG-gated CTA, for the English population, the
LAR in 50-year-old males undergoing a single examina-
tion was 0.112% (i.e. 1 case in 893 males), 0.096% (1 in
1042) and 0.084% (1 in 1190) for pitches of 0.2, 0.22 and
0.24, respectively; in 50-year-old females the correspond-
ing values were 0.227% (1 in 441), 0.192% (1 in 521) and
0.170% (1 in 588), respectively. For the US population, the
LAR in 50-year-old males was 0.103% (1 in 971 males),
0.087% (1 in 1149) and 0.077% (1 in 1299) for pitches of
0.2, 0.22 and 0.24, respectively; in 50-year-old females the
corresponding values were 0.228% (1 in 439), 0.193% (1
in 518) and 0.171% (1 in 585), respectively. For the Hong
Kong population, the LAR in 50-year-old males was
0.137 % (1 in 730), 0.116% (1 in 862) and 0.102% (1 in 980)
for pitches of 0.2, 0.22 and 0.24, respectively; in 50-year-
old females the corresponding values were 0.370% (1 in
270), 0.313% (1 in 319) and 0.287% (1 in 437), respectively.
The risks for the USA population are similar to those for
the English population (less than 10% difference,
depending on age), whereas the risks for the Hong
Kong population were about 1.2–1.9 times the risks for
the English population.
For prospectively ECG-gated CTA, the LARs were
0.014% and 0.035% for 50-year-old English males and
females, respectively. For 50-year-old USA males and
females, the LARs were 0.013% and 0.036%, respectively.
For 50-year-old Hong Kong males and females, the LARs
were 0.017% and 0.060%, respectively. Similar to retro-
spectively ECG-gated CTA, the LARs for the Hong Kong
population were around 1.2–2.0 times those of the
English population. Comparing retrospective and pro-
spective ECG-gating techniques, the LARs of cancer
incidence from retrospectively ECG-gated CTA were
between 4 and 8 times higher than those from prospec-
tively ECG-gated CTA (Figure 1) across all ages in
England, the USA and Hong Kong.
Table 1. Radiation doses from a single coronary CT angiography examination
Organ Dose from coronary CT angiography (mSv)
VCT, 50 bpm VCT, 60 bpm VCT, 70 bpm VCT XT
WT Male Female Male Female Male Female Male/female
Gonad 0.08 0.0 0.1 0.0 0.1 0.0 0.1 0.0
Colon 0.12 0.2 0.1 0.2 0.1 0.1 10.0 0.0
Stomach 0.12 11.1 9.7 9.5 8.3 8.5 7.3 1.2
Lung 0.12 72.9 61.8 61.8 52.3 54.4 46.2 9.7
Breast 0.12 73.9 62.8 62.8 53.3 55.3 47.1 12
Bone marrow 0.12 15.2 13.2 13.3 11.4 11.8 10.0 2.0
Thyroid 0.04 2.2 1.9 1.9 1.6 1.7 1.5 0.2
Liver 0.04 19.2 16.2 16.2 13.3 13.6 11.8 1.8
Bladder 0.04 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Oesophagus 0.04 71.9 61.8 61.8 52.3 53.5 45.3 5.7
Bone surface 0.01 27.3 23.3 23.8 20.0 20.9 17.2 3.5
Skin 0.01 10.1 9.0 9.0 7.7 7.9 6.7 1.3
Brain 0.01 0.1 0.1 0.1 0.1 0.1 0.1 0.0
Remainder tissues 0.13 2.8 2.4 2.3 2.0 2.1 1.8 0.3
Effective dose (mSv) – 27.7 23.6 23.6 20.0 20.7 18.8 3.7
WT, tissue-weighting factors recommended in the International Committee on Radiological Protection (ICRP) publication 103
[27].
B Huang, J Li, M W-M Law et al
154 The British Journal of Radiology, February 2010
The LARs for both protocols were comparatively
higher in younger cubiects and decreased with increas-
ing age for both genders in England, the USA and Hong
Kong (Figure 1). For example, for retrospectively ECG-
gated CTA with pitch 0.2, the LAR of Hong Kong males
decreased from 0.229% at 20 years of age to 0.042% at 80
years of age. LARs for women were higher than for men
across all ages; this was mainly because females’ breasts
receive high doses and carry a higher relative risk of
developing cancer.
Comparing with the baseline lifetime cancer incidence,
the proportion of LAR that contributed to total lifetime
cancer risk (sum of LAR and baseline lifetime cancer
incidence) was, for retrospectively ECG-gated CTA, 0.1%–
0.4% and 0.5%–1.6% for males and females, respectively, in
England, 0.1%–0.4% and 0.3%–1.5% for males and females,
respectively, in the USA and 0.3%–0.7% and 1.3%–2.9%
for males and females, respectively, in Hong Kong. For
prospectively ECG-gated CTA, the proportion of LAR that
contributed to total lifetime cancer risk was 0.03%–0.05%
and 0.10%–0.26% for males and females, respectively, in
England, 0.02%–0.05% and 0.07%–0.25% for males and
females, respectively, in the USA, and 0.05%–0.09% and
0.3%–0.5% for males and females, respectively, in Hong
Kong. Again, this was comparatively higher in younger
ages and decreased with increasing age.
Discussion
Our dose results for both retrospectively and prospec-
tively ECG-gated coronary CTAs are similar to the
published dose reports in the literature using 64-MDCT
[10, 13, 14, 17]. To make comparisons with previous
published studies in which effective doses were calculated
based on tissue weighting factors in ICRP publication 60,
the effective dose in the present study was recalculated
according to ICRP publication 60. For retrospectively ECG-
gated coronary CTA (pitch 0.2), the recalculated dose was
found to be 21 mSv for males and 18 mSv for females, in
good accordance with the average effective dose estimated
to be 20.0 ¡ 3.5 mSv by Hirai et al [13]. For prospectively
ECG-gated CTA, the reported effective doses ranged from
3.0 mSv to 4.2 mSv [13, 14, 17], which are also similar to
the recalculated effective dose in our study (2.6 mSv).
Einstein et al [10] reported the LAR associated with
retrospectively ECG-gated coronary CTA on 64-slice
MDCT to be 0.70% and 0.15% for 20-year-old US women
and men, respectively, similar to our estimated LAR
results (Figure 1).
Our results showed that both the doses and risks
change markedly with heart rate using the retrospective
ECG-gating technique (Table 1 and Figure 1). This has
been reported and explained in our previous publication
[33]. Briefly, there are two reasons for this observation.
First, for lower heart rates a lower pitch is used, as this is
necessary to avoid discontinuities in images of the heart
from consecutive cardiac cycles [34]; however, this
would then increase the radiation dose when other CT
parameters remain the same [35]. Second, the tube
current during CT scan is different for different heart
rates with the use of ECG modulation, and this would
affect the dose. The effective doses from prospectively
ECG-gated CTA were less than 20% of those from
retrospectively ECG-gated CTA (Table 1) and the esti-
mated LARs less than 25% (Figure 1), even for the
highest pitch. This was observed in both males and
females in England, the USA and Hong Kong across all
ages. The lower dose is a result of the shortened time
period of radiation exposure, because the other para-
meters of the two protocols in our study were similar.
For example, in our study, the total exposure time of
retrospectively ECG-gated CTA is up to 7 s (pitch 0.2),
Table 2. Radiation doses and cancer risks reported from various CT studies and for the background radiation
Study type and reference Effective doseb (mSv) Lifetime excess cancer incidence (%) (mainly for
20-year-old patients)
Retrospectively ECG-gated coronary CTAa 18.8–27.7 0.23 (males), 0.70 (females)
Prospectively ECG-gated coronary CTAa 3.7 0.03 (males), 0.11 (females)
Head CT [38] 8.7 (to thyroid only) 0.039 (to thyroid gland only)
Chest CT [39,40] 5.4 0.025
Paediatric abdominal CT [41] 11 0.18
Whole body CT [20] 12.1 0.135 (mortality)
Background radiation per year [42] 3 –
aData obtained from the present study.
bEffective dose given for an average of genders.
Table 3. Table of lifetime attributable risks (LAR) of cancer
incidence for the English population
Cancer site Exposed age (years)
20 30 40 50 60 70 80
Male
Stomach 51 36 35 33 28 19 8
Colon 172 122 119 110 92 61 26
Liver 29 20 20 18 15 10 4
Lung 162 111 111 106 94 70 37
Prostate 42 30 30 28 23 13 6
Bladder 92 67 66 65 58 42 21
Other solid 340 215 190 158 115 67 27
Thyroid 17 7 6 6 5 4 2
Female
Stomach 57 40 39 36 32 24 13
Colon 101 71 69 64 54 38 18
Liver 27 19 19 17 14 10 5
Lung 347 238 236 226 200 151 79
Breast 407 240 135 67 30 12 4
Uterus 2 1 1 1 1 1 0
Ovary 54 38 34 29 22 13 6
Bladder 97 69 68 66 60 46 25
Other solid 403 260 213 176 129 80 36
Thyroid 71 29 24 20 16 12 7
The numbers shown are cancer cases in the lifetime of
100 000 persons exposed to a radiation dose of 100 mSv.
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whereas for the prospectively ECG-gated scan it is only
about 1 s (three times a 0.35 s rotation time).
Compared with that of retrospectively ECG-gated
CTA, image quality of prospectively ECG-gated CTA
has been reported to be at least similar [17] or even
significantly higher [18]. Hence, prospectively ECG-
gated CTA is a promising method for evaluating
coronary arteries, owing to its non-invasive nature, good
image quality and lower radiation dose. The prospective
ECG-gating technique does have some limitations,
however. First, it cannot be applied in patients with
cardiac arrhythmias [6], because the time-point of
triggering the CT scan in the cardiac cycle can be
estimated only from the preceding cardiac cycle. Second,
image quality is more severely degraded at higher heart
rates (.70 bpm) in patients imaged with prospective
gating as compared with retrospective gating [36]. Third,
prospective gating does not allow for cardiac functional
analysis, which requires reconstruction of images at all
time-points during the cardiac cycle [36]. Finally,
prospective ECG gating is performed with an axial
rather than a helical scan and therefore does not allow
for the acquisition of true volumetric raw data; such data
can be potentially useful in the correction of motion
artefacts [37].
LARs were calculated based on the dose from the CT
protocols used in our clinic, hence there might be some
variation in risks, depending on the protocols used
Figure 1. Estimated lifetime attributable risks of cancer incidence associated with radiation dose from a single
electrocardiogram (ECG)-gated CT angiography examination at different ages. Retrospectively ECG-gated CT angiography
was studied on LightSpeed VCT with three different heart rates (50, 60 and 70 bpm) corresponding to different pitches (0.2, 0.22
and 0.24); prospectively ECG-gated CT angiography was studied on LightSpeed VCT XT. The risks to (a) English males, (b) English
females, (c) USA males, (d) USA females, (e) Hong Kong males and (f) Hong Kong females are shown independently.
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across centres and in different countries. Nevertheless,
our results, allowing comparisons of the computed risks
among the three populations in the UK, USA and Hong
Kong, are also of interest. As the life tables and cancer
statistics data for the English and US populations are
similar [28, 29], the LARs for these two populations
showed little difference (Figure 1). For the same radia-
tion dose exposure, cancer risks to the Hong Kong
population were found to be higher than for the US
population (or English population), as found in our
previous study [30, 33]. This is due to the longer life
expectancy in the Hong Kong population and the fact
that this population has higher baseline cancer incidence
in most of the organs that are more sensitive to radiation
dose [30]. As the US and English populations have a
higher baseline lifetime cancer incidence than the Hong
Kong population plus a lower LAR, the proportion
contributed by the LAR to total cancer incidence was
lower in the USA and the English populations than in the
Hong Kong population. Hence, our results suggest that
radiation risk from coronary CTA may have a greater
impact on the Hong Kong population than on the USA
and English populations.
There are limitations in our estimation of doses and
cancer risks in this study. According to Groves et al [25],
the doses simulated using ImPACT are about 15% lower
than the doses measured by them using thermolumines-
cent detectors directly. This underestimation by the
ImPACT spreadsheet may be attributed to differences
between the Rando humanoid phantom (used for
measurement in the work of Groves et al [25]) and the
MIRD phantoms (used in ImPACT). As ImPACT results
are used to determine organ doses for a standard size
person, variations in patient size and tissue composition
can lead to discrepancies in the organ dose estimation.
Despite these variations, the doses simulated using
ImPACT are robust enough and have been reported
widely in the literature [20–25]. The limitations in
calculating the LAR of cancer incidence have been
discussed in our previous study [30]. Briefly, these
limitations are twofold: first, their are uncertainties in
the method for estimating the cancer risk according to
the principles of the BEIR VII report [15]; second, there
are no experimental data to verify the linear extrapola-
tion assumption for doses in the range of CTA (i.e. less
than 100 mSv). In addition, one should bear in mind that
the BEIR VII risk estimates are applicable to the general
population with the typical life expectancy for age and
sex, as our LAR tables were set up based on these data.
These estimates are less applicable in individual subjects
with decreased life expectancy, for example from
exposure to risk factors and chronic illnesses (such as
patients with post-acute myocardial infarction).
Conclusion
According to our study, radiation doses of up to
27.7 mSv and a lifetime risk of cancer incidence of up to
0.37% (for 50-year-old subjects) are associated with retro-
spectively ECG-gated coronary CTA. By contrast, pro-
spectively ECG-gated coronary CTA dramatically reduces
the doses and cancer risks by up to 86% (dose) and 88%
(cancer risk), respectively. Prospectively ECG-gated CTA,
when feasible, is the preferred choice in evaluating the
coronary arteries, in terms of minimising radiation
exposure. However, retrospectively ECG-gated coronary
CTA is still the technique used for patients when the
prospectively ECG-gated technique is not suitable or is
unavailable. In this case, CT protocols should be tailored to
decrease the potential detriments of radiation exposure.
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